US Stock MarketDetailed Quotes

CYTO Altamira Therapeutics

Watchlist

1.6200
+0.0500+3.18%

Close May 1 16:00 ET

1.6200
0.00000.00%

Post 19:07 ET

3.63MMarket Cap-188P/E (TTM)

Altamira Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(Q4)Dec 31, 2018

(Q3)Sep 30, 2018

(Q2)Jun 30, 2018

(Q1)Mar 31, 2018

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-32.57%-11.51M

36.49%-8.68M

-182.29%-13.67M

42.29%-4.84M

36.57%-8.39M

45.49%-13.23M

70.09%-1.93M

15.62%-4.02M

63.37%-2.3M

26.48%-4.98M

Net income from continuing operations

85.41%-3.87M

-55.51%-26.53M

-108.03%-17.06M

-23.65%-8.2M

42.31%-6.63M

52.90%-11.5M

19.51%-3.69M

50.43%-2.98M

43.09%-3.08M

79.22%-1.75M

Operating gains losses

202.62%398.22K

-296.47%-388.05K

-91.57%197.52K

488.83%2.34M

45.16%-602.29K

55.24%-1.1M

261.96%2.84M

-1,551.68%-298.9K

37.31%-550.62K

-2,033.32%-3.09M

Depreciation and amortization

0.35%119.3K

55.70%118.89K

281.10%76.36K

-35.00%20.04K

-57.61%30.82K

-40.78%72.71K

-58.72%11.05K

-50.58%15.35K

-28.57%22.86K

-28.82%23.45K

Deferred tax

-866.67%-99.85K

-147.78%-10.33K

201.58%21.62K

89.02%-21.28K

-219.52%-193.84K

1,012.49%162.18K

2,669.94%188.36K

-6.52%-8.73K

-6.56%-8.73K

-6.53%-8.73K

Other non cash items

-330.02%-4.2M

945.28%1.82M

-49.65%174.59K

28,678.01%346.78K

-99.92%1.21K

-39.40%1.57M

-90.34%87.69K

-43.66%228.79K

53.40%602.12K

-26.44%654.31K

Change In working capital

-219.14%-4.24M

1,884.39%3.56M

-40.31%179.39K

124.55%300.52K

50.51%-1.22M

-428.22%-2.47M

-12.62%-1.29M

-269.69%-1.18M

206.11%550.13K

-211.30%-553.02K

-Change in receivables

113.57%14.06K

69.54%-103.6K

-233.67%-340.12K

1,444.45%254.44K

-2.91%-18.93K

-119.70%-18.39K

-119.16%-11.24K

471.19%117.27K

-91.55%4.31K

-249.36%-128.72K

-Change in inventory

-138.65%-319.82K

198.61%827.58K

---839.22K

--0

----

-Change in prepaid assets

-77.00%197.01K

166.00%856.43K

-928.25%-1.3M

288.87%156.66K

-127.50%-82.95K

0.65%301.63K

175.95%156.04K

-121.50%-26.51K

14.58%351.22K

-337.83%-179.12K

-Change in payables and accrued expense

-308.78%-4.13M

-25.48%1.98M

2,502.23%2.66M

90.15%-110.58K

59.29%-1.12M

-220.05%-2.76M

-43.73%-1.43M

-330.24%-1.27M

122.22%194.61K

-153.49%-245.18K

Cash from discontinued investing activities

Operating cash flow

-32.57%-11.51M

36.49%-8.68M

-182.29%-13.67M

42.29%-4.84M

36.57%-8.39M

45.49%-13.23M

70.09%-1.93M

15.62%-4.02M

63.37%-2.3M

26.48%-4.98M

Investing cash flow

Cash flow from continuing investing activities

167.46%1.44M

38.89%-2.14M

-51.41%-3.51M

22.85%-2.31M

-64.61%-3M

-1,733.98%-1.82M

-29,224.30%-1.87M

207.96%68.16K

-235.64%-19.64K

Net PPE purchase and sale

----

-193.31%-63.6K

1,166.83%68.16K

--0

----

--0

Net intangibles purchase and sale

--0

35.57%-2.14M

-43.66%-3.33M

21.65%-2.32M

-56.26%-2.96M

-1,190.16%-1.89M

---1.87M

--0

----

Net business purchase and sale

--1.43M

--0

----

Net investment purchase and sale

--10.04K

--0

---179.1K

----

Cash from discontinued investing activities

Investing cash flow

167.46%1.44M

38.89%-2.14M

-51.41%-3.51M

22.85%-2.31M

-64.61%-3M

-1,733.98%-1.82M

-29,224.30%-1.87M

207.96%68.16K

-235.64%-19.64K

--0

Financing cash flow

Cash flow from continuing financing activities

8.03%10.62M

48.66%9.83M

-61.01%6.61M

129.89%16.96M

28.70%7.38M

-30.27%5.73M

269.82%3.91M

476.03%4.92M

-1,822.01%-6.06M

-66.28%2.96M

Net issuance payments of debt

-82.29%1.05M

8,723.55%5.92M

-104.51%-68.7K

204.07%1.52M

84.22%-1.46M

-344.27%-9.27M

-0.59%-1.07M

---1.17M

---5.61M

---1.43M

Net common stock issuance

----

--7M

--0

-43.33%5.28M

Cash dividends paid

--0

Proceeds from stock option exercised by employees

165.16%10.51M

-42.09%3.96M

-57.43%6.84M

64.14%16.07M

-43.87%9.79M

--17.45M

----

Net other financing activities

-2,115.16%-786.29K

77.36%-35.5K

75.38%-156.82K

32.86%-636.86K

52.72%-948.62K

-29.60%-2.01M

88.64%-149.99K

---851.69K

---349.91K

-188.00%-654.99K

Cash from discontinued financing activities

Financing cash flow

8.03%10.62M

48.66%9.83M

-61.01%6.61M

129.89%16.96M

28.70%7.38M

-30.27%5.73M

269.82%3.91M

476.03%4.92M

-1,822.01%-6.06M

-66.28%2.96M

Net cash flow

Beginning cash position

-98.44%15.4K

-91.26%984.19K

713.08%11.26M

-74.32%1.38M

-63.98%5.39M

-53.85%14.97M

-73.97%5.26M

-83.15%4.42M

-62.61%12.65M

-53.85%14.97M

Current changes in cash

155.93%555.42K

90.60%-993.07K

-207.77%-10.56M

344.08%9.8M

56.92%-4.02M

42.29%-9.32M

102.04%110.18K

115.77%967.33K

-27.18%-8.38M

-202.57%-2.02M

Effect of exchange rate changes

91.93%46.59K

-91.61%24.28K

304.60%289.39K

823.62%71.53K

103.01%7.74K

80.41%-257.64K

-85.41%25.15K

-241.97%-131.22K

114.77%150.17K

46.41%-301.74K

End cash Position

3,910.45%617.41K

-98.44%15.4K

-91.26%984.19K

713.08%11.26M

-74.32%1.38M

-63.98%5.39M

-73.97%5.26M

-83.15%4.42M

-62.61%12.65M

Free cash flow

-6.33%-11.51M

36.31%-10.83M

-137.45%-17M

37.27%-7.16M

24.54%-11.41M

38.09%-15.12M

41.13%-3.8M

16.88%-4.02M

63.06%-2.32M

27.28%-4.98M

Currency Unit

CHF

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(Q4)Dec 31, 2018	(Q3)Sep 30, 2018	(Q2)Jun 30, 2018	(Q1)Mar 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-32.57%-11.51M	36.49%-8.68M	-182.29%-13.67M	42.29%-4.84M	36.57%-8.39M	45.49%-13.23M	70.09%-1.93M	15.62%-4.02M	63.37%-2.3M	26.48%-4.98M
Net income from continuing operations	85.41%-3.87M	-55.51%-26.53M	-108.03%-17.06M	-23.65%-8.2M	42.31%-6.63M	52.90%-11.5M	19.51%-3.69M	50.43%-2.98M	43.09%-3.08M	79.22%-1.75M
Operating gains losses	202.62%398.22K	-296.47%-388.05K	-91.57%197.52K	488.83%2.34M	45.16%-602.29K	55.24%-1.1M	261.96%2.84M	-1,551.68%-298.9K	37.31%-550.62K	-2,033.32%-3.09M
Depreciation and amortization	0.35%119.3K	55.70%118.89K	281.10%76.36K	-35.00%20.04K	-57.61%30.82K	-40.78%72.71K	-58.72%11.05K	-50.58%15.35K	-28.57%22.86K	-28.82%23.45K
Deferred tax	-866.67%-99.85K	-147.78%-10.33K	201.58%21.62K	89.02%-21.28K	-219.52%-193.84K	1,012.49%162.18K	2,669.94%188.36K	-6.52%-8.73K	-6.56%-8.73K	-6.53%-8.73K
Other non cash items	-330.02%-4.2M	945.28%1.82M	-49.65%174.59K	28,678.01%346.78K	-99.92%1.21K	-39.40%1.57M	-90.34%87.69K	-43.66%228.79K	53.40%602.12K	-26.44%654.31K
Change In working capital	-219.14%-4.24M	1,884.39%3.56M	-40.31%179.39K	124.55%300.52K	50.51%-1.22M	-428.22%-2.47M	-12.62%-1.29M	-269.69%-1.18M	206.11%550.13K	-211.30%-553.02K
-Change in receivables	113.57%14.06K	69.54%-103.6K	-233.67%-340.12K	1,444.45%254.44K	-2.91%-18.93K	-119.70%-18.39K	-119.16%-11.24K	471.19%117.27K	-91.55%4.31K	-249.36%-128.72K
-Change in inventory	-138.65%-319.82K	198.61%827.58K	---839.22K	--0	--0	----	----	----	----	----
-Change in prepaid assets	-77.00%197.01K	166.00%856.43K	-928.25%-1.3M	288.87%156.66K	-127.50%-82.95K	0.65%301.63K	175.95%156.04K	-121.50%-26.51K	14.58%351.22K	-337.83%-179.12K
-Change in payables and accrued expense	-308.78%-4.13M	-25.48%1.98M	2,502.23%2.66M	90.15%-110.58K	59.29%-1.12M	-220.05%-2.76M	-43.73%-1.43M	-330.24%-1.27M	122.22%194.61K	-153.49%-245.18K
Cash from discontinued investing activities
Operating cash flow	-32.57%-11.51M	36.49%-8.68M	-182.29%-13.67M	42.29%-4.84M	36.57%-8.39M	45.49%-13.23M	70.09%-1.93M	15.62%-4.02M	63.37%-2.3M	26.48%-4.98M
Investing cash flow
Cash flow from continuing investing activities	167.46%1.44M	38.89%-2.14M	-51.41%-3.51M	22.85%-2.31M	-64.61%-3M	-1,733.98%-1.82M	-29,224.30%-1.87M	207.96%68.16K	-235.64%-19.64K	0
Net PPE purchase and sale	----	----	----	----	-193.31%-63.6K	1,166.83%68.16K	--0	----	----	--0
Net intangibles purchase and sale	--0	35.57%-2.14M	-43.66%-3.33M	21.65%-2.32M	-56.26%-2.96M	-1,190.16%-1.89M	---1.87M	--0	----	----
Net business purchase and sale	--1.43M	--0	--0	----	----	----	----	----	----	----
Net investment purchase and sale	--10.04K	--0	---179.1K	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	167.46%1.44M	38.89%-2.14M	-51.41%-3.51M	22.85%-2.31M	-64.61%-3M	-1,733.98%-1.82M	-29,224.30%-1.87M	207.96%68.16K	-235.64%-19.64K	--0
Financing cash flow
Cash flow from continuing financing activities	8.03%10.62M	48.66%9.83M	-61.01%6.61M	129.89%16.96M	28.70%7.38M	-30.27%5.73M	269.82%3.91M	476.03%4.92M	-1,822.01%-6.06M	-66.28%2.96M
Net issuance payments of debt	-82.29%1.05M	8,723.55%5.92M	-104.51%-68.7K	204.07%1.52M	84.22%-1.46M	-344.27%-9.27M	-0.59%-1.07M	---1.17M	---5.61M	---1.43M
Net common stock issuance	----	----	----	----	----	----	----	--7M	--0	-43.33%5.28M
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Proceeds from stock option exercised by employees	165.16%10.51M	-42.09%3.96M	-57.43%6.84M	64.14%16.07M	-43.87%9.79M	--17.45M	----	----	----	----
Net other financing activities	-2,115.16%-786.29K	77.36%-35.5K	75.38%-156.82K	32.86%-636.86K	52.72%-948.62K	-29.60%-2.01M	88.64%-149.99K	---851.69K	---349.91K	-188.00%-654.99K
Cash from discontinued financing activities
Financing cash flow	8.03%10.62M	48.66%9.83M	-61.01%6.61M	129.89%16.96M	28.70%7.38M	-30.27%5.73M	269.82%3.91M	476.03%4.92M	-1,822.01%-6.06M	-66.28%2.96M
Net cash flow
Beginning cash position	-98.44%15.4K	-91.26%984.19K	713.08%11.26M	-74.32%1.38M	-63.98%5.39M	-53.85%14.97M	-73.97%5.26M	-83.15%4.42M	-62.61%12.65M	-53.85%14.97M
Current changes in cash	155.93%555.42K	90.60%-993.07K	-207.77%-10.56M	344.08%9.8M	56.92%-4.02M	42.29%-9.32M	102.04%110.18K	115.77%967.33K	-27.18%-8.38M	-202.57%-2.02M
Effect of exchange rate changes	91.93%46.59K	-91.61%24.28K	304.60%289.39K	823.62%71.53K	103.01%7.74K	80.41%-257.64K	-85.41%25.15K	-241.97%-131.22K	114.77%150.17K	46.41%-301.74K
End cash Position	3,910.45%617.41K	-98.44%15.4K	-91.26%984.19K	713.08%11.26M	-74.32%1.38M	-63.98%5.39M	-63.98%5.39M	-73.97%5.26M	-83.15%4.42M	-62.61%12.65M
Free cash flow	-6.33%-11.51M	36.31%-10.83M	-137.45%-17M	37.27%-7.16M	24.54%-11.41M	38.09%-15.12M	41.13%-3.8M	16.88%-4.02M	63.06%-2.32M	27.28%-4.98M
Currency Unit	CHF	CHF	CHF	CHF	CHF	CHF	CHF	CHF	CHF	CHF
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall